During Tuesday morning trading, shares of biotechnology company Femasys Inc (FEMY) tumbled 35.7% after the company announced a public offering to raise $8 million in capital. The proceeds from the offering will be utilized to support the company's commercial expansion initiatives and product development programs.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.